The WACC of Prostatype Genomics AB (PROGEN.ST) is 5.5%.
| Range | Selected | |
| Cost of equity | 5.10% - 6.70% | 5.90% |
| Tax rate | 20.60% - 20.90% | 20.75% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 4.8% - 6.2% | 5.5% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.5 | 0.53 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.10% | 6.70% |
| Tax rate | 20.60% | 20.90% |
| Debt/Equity ratio | 0.27 | 0.27 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 4.8% | 6.2% |
| Selected WACC | 5.5% | |